FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma
pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma
Maritime Resources: A Low-risk Path to Gold Production in One of the World’s Top Mining Jurisdictions
Homerun Resources Inc. Announces New Homerun Energy Website and "The Hub" AI-Powered Platform for Energy Management